Linhai J. Zhu
No. 79 Qingchun Road
Hangzhou, 310003, China
Hangzhou, 310003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Single-cell hdWGCNA identifies checkpoint inhibitor pneumonitis-linked CD4 + T-cell subsets driving immunotherapy response and prognosis in lung cancer.
Journal: Journal of cancer research and clinical oncology
Published: April 15, 2026
The Predictive Value of Neutrophil-To-Lymphocyte Ratio (NLR) for Response to Neoadjuvant Immunochemotherapy in Resectable IIA-IIIB Non-Small Cell Lung Cancer in Real-World Practice.
Journal: Thoracic cancer
Published: March 10, 2026
Surgery versus definitive radiotherapy after induction immunochemotherapy for stage II and III non-small cell lung cancer: A multicenter, pragmatic analysis.
Journal: The Journal of thoracic and cardiovascular surgery
Published: January 06, 2026
A Biomimetic Li2Si2O5 Composite with High Energy Absorption for Endocrowns.
Journal: Journal of dental research
Published: October 17, 2025
Effect of triply periodic minimal surfaces structure and ceramic volume fraction on mechanical properties of polymer-infiltrated ceramic network composites fabricated by additive manufactured zirconia and resin
Journal: Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
Published: May 30, 2025
Application Research of Narrative Care to the Management of Symptom Clusters and Post-traumatic Growth in Patients Undergoing Lung Cancer Surgery
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: February 23, 2025
Efficacy and safety of anlotinib plus EGFR tyrosine kinase inhibitors in slow- or locally progressing non-small cell lung cancer after adjuvant therapy.
Journal: Translational lung cancer research
Published: February 18, 2025
Efficacy of neoadjuvant immunochemotherapy in the treatment of stage III non-small-cell lung cancer with cancer driver gene mutations.
Journal: Translational lung cancer research
Published: January 16, 2025
Two versus three to four cycles of neoadjuvant immunochemotherapy for stage IB-IIIB non-small cell lung cancer: a real-world study.
Journal: Journal of thoracic disease
Published: December 26, 2024
Surgery for lung cancer: Time waits for no one.
Journal: The Journal of thoracic and cardiovascular surgery
Published: December 23, 2024
Neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma in real-world practice: an analysis of the clinical outcomes and long-term survival, and the feasibility of using major pathological response as a surrogate endpoint.
Journal: European journal of medical research
Published: December 04, 2024
Neoadjuvant immunochemotherapy versus chemotherapy for elderly patients with IB-IIIB non-small-cell lung cancer in real-world practice.
Journal: BMC cancer
Published: November 29, 2024
Last Updated: 09/26/2026